Suppr超能文献

评估Binax NOW免疫层析检测法与聚合酶链反应及显微镜检查法在检测归国旅行者疟疾中的应用。

Evaluation of the Binax NOW ICT test versus polymerase chain reaction and microscopy for the detection of malaria in returned travelers.

作者信息

Farcas Gabriella A, Zhong Kathleen J Y, Lovegrove Fiona E, Graham Christopher M, Kain Kevin C

机构信息

Institute of Medical Science, Faculty of Medicine University of Toronto, Toronto, Ontario, Canada.

出版信息

Am J Trop Med Hyg. 2003 Dec;69(6):589-92.

Abstract

Microscopic detection of Plasmodium species has been the reference standard for the diagnosis of malaria for more than a century. However, maintaining a sufficient level of expertise in microscopic diagnosis can be challenging, particularly in non-endemic countries. The objective of this study was to compare a new rapid malaria diagnostic device (NOW ICT Malaria Test; Binax, Inc., Portland, ME) to polymerase chain reaction (PCR) and expert microscopy for the diagnosis of malaria in 256 febrile returned travelers. Compared with PCR, the NOW ICT test showed a sensitivity of 94% for the detection of P. falciparum malaria (96% for pure P. falciparum infection) and 84% for non-P. falciparum infections (87% for pure P. vivax infections and 62% for pure P. ovale and P. malariae infections), with an overall specificity of 99%. The Binax NOW ICT may represent a useful adjunct for the diagnosis of P. falciparum and P. vivax malaria in febrile returned travelers.

摘要

一个多世纪以来,疟原虫种类的显微镜检测一直是疟疾诊断的参考标准。然而,要保持足够水平的显微镜诊断专业知识具有挑战性,尤其是在非疟疾流行国家。本研究的目的是在256名发热的归国旅行者中,将一种新型快速疟疾诊断设备(NOW ICT疟疾检测;Binax公司,缅因州波特兰)与聚合酶链反应(PCR)和专家显微镜检查用于疟疾诊断进行比较。与PCR相比,NOW ICT检测对恶性疟原虫疟疾检测的灵敏度为94%(纯恶性疟原虫感染为96%),对非恶性疟原虫感染的灵敏度为84%(纯间日疟原虫感染为87%,纯卵形疟原虫和三日疟原虫感染为62%),总体特异性为99%。Binax NOW ICT可能是发热归国旅行者中恶性疟原虫和间日疟原虫疟疾诊断的有用辅助手段。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验